The role of bariatric surgery in the treatment of diabetes

Therapeutic Advances in Chronic Disease

Volumn 5, Issue 3, 2014, Pages 149-157

  Tham, Ji Chung ^a   Howes, Noah ^b   Roux, Carel W ^c  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b MUSGROVE PARK HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bariatric surgery; Diabetes mellitus; Obesity

Indexed keywords

C REACTIVE PROTEIN; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OCTREOTIDE; PEPTIDE YY; TRIACYLGLYCEROL;

BARIATRIC SURGERY; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; DIGESTIVE SURGICAL EQUIPMENT; GASTRIC BAND; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; WEIGHT REDUCTION;

EID: 84898981364     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622313513313     Document Type: Review

References (71)

1. ASMBS Clinical Issues Committee (2012) Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 8: e21–e26.
2. Bendewald F. Choi J. Blythe L. Selzer D. Ditslear J. Mattar S. (2011) Comparison of hand-sewn, linear-stapled, and circular-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg 21: 1671–1675.
3. Bjorklund P. Laurenius A. Een E. Olbers T. Lonroth H. Fandriks L. (2010) Is the Roux limb a determinant for meal size after gastric bypass surgery? Obes Surg 20: 1408–1414.
4. Borg C. Le Roux C. Ghatei M. Bloom S. Patel A. Aylwin S. (2006) Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 93: 210–215.
5. Breen D. Rasmussen B. Kokorovic A. Wang R. Cheung G. Lam T. (2012) Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med 18: 950–955.
6. Brown W. Burton P. Anderson M. Korin A. Dixon J. Hebbard G. et al. (2008) Symmetrical pouch dilatation after laparoscopic adjustable gastric banding: incidence and management. Obes Surg 18: 1104–1108.
7. Brunetti P. (2007) The lean patient with type 2 diabetes: characteristics and therapy challenge. Int J Clin Pract Suppl 61: 1776.
8. Buchwald H. Avidor Y. Braunwald E. Jensen M. Pories W. Fahrbach K. et al. (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 1724–1737.
9. Bueter M. Lowenstein C. Olbers T. Wang M. Cluny N. Bloom S. et al. (2010) Gastric bypass increases energy expenditure in rats. Gastroenterology 138: 1845–1853.
10. Burton P. Yap K. Brown W. Laurie C. O'Donnell M. Hebbard G. et al. (2010) Effects of adjustable gastric bands on gastric emptying, supra- and infraband transit and satiety: a randomized double-blind crossover trial using a new technique of band visualization. Obes Surg 20: 1690–1697.
11. Burton P. Yap K. Brown W. Laurie C. O'Donnell M. Hebbard G. et al. (2011) Changes in satiety, supra- and infraband transit, and gastric emptying following laparoscopic adjustable gastric banding: a prospective follow-up study. Obes Surg 21: 217–223.
12. de Jonge C. Rensen S. Verdam F. Vincent R. Bloom S. Buurman W. et al. (2013) Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 23: 1354–1360.
13. de Moura E. Martins B. Lopes G. Orso I. de Oliveira S. Galvão Neto M. et al. (2012) Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 14: 183–189.
14. Dixon A. Dixon J. O'Brien P. (2005) Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 90: 813–819.
15. Dixon J. O'Brien P. Playfair J. Chapman L. Schachter L. Skinner S. et al. (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299: 316–323.
16. Edwards M. Jones D. Ellsmere J. Grinbaum R. Schneider B. (2007) Anastomotic leak following antecolic versus retrocolic laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 17: 292–297.
17. Escalona A. Pimentel F. Sharp A. Becerra P. Slako M. Turiel D. et al. (2012) Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 255: 1080–1085.
18. Fenske W. Bueter M. Miras A. Ghatei M. Bloom S. Le Roux C. (2012) Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Int J Obes (Lond) 36: 379–384.
19. Fenske W. Dubb S. Bueter M. Seyfried F. Patel K. Tam F. et al. (2013) Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis 9: 559–568.
20. Frisch A. Chandra P. Smiley D. Peng L. Rizzo M. Gatcliffe C. et al. (2010) Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 33: 1783–1788.
21. Gaede P. Vedel P. Larsen N. Jensen G. Parving H. Pedersen O. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383–393.
22. Gauthier M. Ruderman N. (2010) Adipose tissue inflammation and insulin resistance: all obese humans are not created equal. Biochem J 430: e1–e4.
23. Gersin K. Keller J. Stefanidis D. Simms C. Abraham D. Deal S. et al. (2007) Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 14: 275–278.
24. Ginter E. Simko V. (2010) Diabetes type 2 pandemic in 21st century. Bratisl Lek Listy 111: 134–137.
25. Giordano S. Salminen P. Biancari F. Victorzon M. (2011) Linear stapler technique may be safer than circular in gastrojejunal anastomosis for laparoscopic Roux-en-Y gastric bypass: a meta-analysis of comparative studies. Obes Surg 21: 1958–1964.
26. Goitein D. Lederfein D. Tzioni R. Berkenstadt H. Venturero M. Rubin M. (2012) Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients–a possible guide for efficient sleeve gastrectomy construction. Obes Surg 22: 617–622.
27. Hallersund P. Sjöström L. Olbers T. Lönroth H. Jacobson P. Wallenius V. et al. (2012) Gastric bypass surgery is followed by lowered blood pressure and increased diuresis – long term results from the Swedish Obese Subjects (SOS) study. PloS ONE 7: e49696.
28. Higa K. Boone K. Ho T. Davies O. (2000) Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg 135: 1029–1033; discussion 1033–1034.
29. Iaconelli A. Panunzi S. de Gaetano A. Manco M. Guidone C. Leccesi L. et al. (2011) Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34: 561–567.
30. Jiménez A. Casamitjana R. Flores L. Viaplana J. Corcelles R. Lacy A. et al. (2012) Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 256: 1023–1029.
31. Kadera B. Portenier D. Yurcisin B. Demaria E. Gaddor M. Jain-Spangler K. (2013) Evidence for a metabolic mechanism in the improvement of type 2 diabetes after sleeve gastrectomy in a rodent model. Surg Obes Relat Dis 9: 447–452.
32. Kashyap S. Bhatt D. Wolski K. Watanabe R. Abdul-Ghani M. Abood B. et al. (2013) Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 36: 2175–2182.
33. Kopp H. Kopp C. Festa A. Krzyzanowska K. Kriwanek S. Minar E. et al. (2003) Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23: 1042–1047.
34. Langer F. Reza Hoda M. Bohdjalian A. Felberbauer F. Zacherl J. Wenzl E. et al. (2005) Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15: 1024–1029.
35. Le Roux C. Bueter M. Theis N. Werling M. Ashrafian H. Löwenstein C. et al. (2011) Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol 301: R1057–R1066.
36. Le Roux C. Welbourn R. Werling M. Osborne A. Kokkinos A. Laurenius A. et al. (2007) Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246: 780–785.
37. Makishima M. Okamoto A. Repa J. Tu H. Learned R. Luk A. et al. (1999) Identification of a nuclear receptor for bile acids. Science 284: 1362–1365.
38. Mason E. Printen K. Blommers T. Scott D. (1978) Gastric bypass for obesity after ten years experience. Int J Obes 2: 197–206.
39. Mingrone G. Panunzi S. de Gaetano A. Guidone C. Iaconelli A. Leccesi L. et al. (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366: 1577–1585.
40. Miras A. Chuah L. Lascaratos G. Faruq S. Mohite A. Shah P. et al. (2012 a) Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care 35: e81.
41. Miras A. Jackson R. Jackson S. Goldstone A. Olbers T. Hackenberg T. et al. (2012 b) Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr 96: 467–473.
42. Müller M. Guber J. Wildi S. Guber I. Clavien P. Weber M. (2007) Three-year follow-up study of retrocolic versus antecolic laparoscopic Roux-en-Y gastric bypass. Obes Surg 17: 889–893.
43. Nakatani H. Kasama K. Oshiro T. Watanabe M. Hirose H. Itoh H. (2009) Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 58: 1400–1407.
44. O'Brien P. (2010) Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol 25: 1358–1365.
45. O'Brien P. Dixon J. (2003) Lap-band: outcomes and results. J Laparoendosc Adv Surg Tech A 13: 265–270.
46. Papamargaritis D. Le Roux C. Sioka E. Koukoulis G. Tzovaras G. Zacharoulis D. (2013) Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 9: 192–201.
47. Patle R. Dubb S. Alaghband-Zadeh J. Sherwood R. Tam F. Frankel A. et al. (2012) Improved blood pressure, nitric oxide and asymmetric dimethylarginine are independent after bariatric surgery. Ann Clin Biochem 49: 589–594.
48. Patti M. Houten S. Bianco A. Bernier R. Larsen P. Holst J. et al. (2009) Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 17: 1671–1677.
49. Peterli R. Steinert R. Woelnerhanssen B. Peters T. Christoffel-Courtin C. Gass M. et al. (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22: 740–748.
50. Pournaras D. Glicksman C. Vincent R. Kuganolipava S. Alaghband-Zadeh J. Mahon D. et al. (2012) The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153: 3613–3619.
51. Pournaras D. Le Roux C. (2009) Obesity, gut hormones, and bariatric surgery. World J Surg 33: 1983–1988.
52. Pournaras D. Osborne A. Hawkins S. Vincent R. Mahon D. Ewings P. et al. (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 252: 966–971.
53. Promintzer-Schifferl M. Prager G. Anderwald C. Mandl M. Esterbauer H. Shakeri-Leidenmühler S. et al. (2011) Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients. Obesity (Silver Spring) 19: 1420–1426.
54. Puri R. Nissen S. Ballantyne C. Barter P. Chapman M. Erbel R. et al. (2013) Factors underlying regression of coronary atheroma with potent statin therapy. Eur Heart J 34: 1818–1825.
55. Ramón J. Salvans S. Crous X. Puig S. Goday A. Benaiges D. et al. (2012) Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg 16: 1116–1122.
56. Rosenthal R. Diaz A. Arvidsson D. Baker R. Basso N. Bellanger D. et al. (2012) International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis 8: 8–19.
57. Sarkhosh K. Birch D. Shi X. Gill R. Karmali S. (2012) The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg 22: 832–837.
58. Schauer P. Kashyap S. Wolski K. Brethauer S. Kirwan J. Pothier C. et al. (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366: 1567–1576.
59. Schouten R. Rijs C. Bouvy N. Hameeteman W. Koek G. Janssen I. et al. (2010) A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 251: 236–243.
60. Shah S. Shah P. Todkar J. Gagner M. Sonar S. Solav S. (2010) Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis 6: 152–157.
61. Sjöström L. (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 273: 219–234.
62. Sjöström L. Narbro K. Sjöström C. Karason K. Larsson B. Wedel H. et al. (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357: 741–752.
63. Sjöström L. Lindroos A.K. Peltonen M. Torgerson J. Bouchard C. Carlsson B. et al. (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med, 351: 2683–93.
64. Vest A. Heneghan H. Agarwal S. Schauer P. Young J. (2012) Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 98: 1763–1777.
65. Vix M. Diana M. Liu K. D'Urso A. Mutter D. Wu H. et al. (2012) Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg 23: 613–621.
66. Wang P. Caspi L. Lam C. Chari M. Li X. Light P. et al. (2008) Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452: 1012–1016.
67. Welbourn R. Fiennes A. Kinsman R. Walton P. (2010) National Bariatric Surgery Registry: first registry report to March 2010. Henley on Thames, UK: Dendrite Clinical Systems Ltd.
68. Werling M. Olbers T. Fändriks L. Bueter M. Lönroth H. Stenlöf K. et al. (2013) Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PloS ONE 8: e60280.
69. WHO (2011) Obesity and overweight. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html (accessed 6 November 2013).
70. Yehoshua R. Eidelman L. Stein M. Fichman S. Mazor A. Chen J. et al. (2008) Laparoscopic sleeve gastrectomy – volume and pressure assessment. Obes Surg 18: 1083–1088.
71. Yusuf S. Sleight P. Pogue J. Bosch J. Davies R. Dagenais G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145–153.